Kawasaki disease in East Mazandaran, Islamic Republic of Iran, 1997-2002

Eastern Mediterranean Health Journal

Volumn 11, Issue 1-2, 2005, Pages 28-35

  Saffar, M J ^a   Reshidighader, F ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN;

AGE DISTRIBUTION; CARDIOVASCULAR DISEASE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INCIDENCE; IRAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; ONSET AGE; PATIENT REFERRAL; RETROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE;

AGE DISTRIBUTION; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INCIDENCE; INFANT; INFANT, NEWBORN; IRAN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATIENT ADMISSION; POPULATION SURVEILLANCE; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SEASONS; SEX DISTRIBUTION; TIME FACTORS; TREATMENT OUTCOME; URBAN HEALTH;

EID: 33644598840     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Dajani AS et al. Diagnosis and therapy of Kawasaki disease in children. Circulation, 1993, 87:1776-80.
2. American Heart Association Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease. Diagnostic guidelines for Kawasaki disease. American journal of diseases of children, 1990, 144:1218-9.
3. Rowley AH, Shulaman ST. Kawasaki syndrome. Pediatric clinics of North America, 1999, 46:313-29.
4. Kato H et al. Fate of coronary aneurysm in Kawasaki disease: Serial coronary angiography and long-term follow-up study. American journal of cardiology, 1982, 49:1758-66.
5. Newburger JW et al. The treatment of Kawasaki syndrome with intravenous gamma-globulin. New England journal of medicine, 1986, 315:341-7.
6. Furusho K et al. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet, 1984, 2(8411):1055-8.
7. Newburger JW et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. New England journal of medicine, 1991, 324: 1633-9.
8. Meissner HC, Leung DYM. Superantigens, conventional antigens and the etiology of Kawasaki syndrome. Pediatric infectious disease journal, 2000, 19(2): 91-4.
9. Petty RE, Cassidy JT. Kawasaki disease In: Petty RE, Cassidy JT, eds. Textbook of pediatric rheumatology, 3rd ed. Philadelphia, WB Saunders, 2001:580-94.
10. Yanagawa H et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics, 2001, 107(3):E33.
11. Taubert KA, Rowley AH, Shulman ST. Seven year national survey of Kawasaki disease and acute rheumatic fever. Pediatric infectious disease journal, 1994, 13(8):704-8.
12. Holman RC et al. Kawasaki syndrome among American Indian and Alaska Native children, 1980 through 1995. Pediatric infectious disease journal, 1999, 18(5):451-5.
13. Bronstein DE, Besser RE, Burns TC. Passive surveillance for Kawasaki disease in San Diego County. Pediatric infectious disease journal, 1997, 16(11):1015-8.
14. Dhillon R et al. Management of Kawasaki disease in the British Isles. Archives of disease in childhood, 1993, 69:631-6.
15. Royle JA et al. Kawasaki disease in Australia 1993-1995. Archives of disease in childhood, 1998, 78:33-9.
16. Du ZD et al. Epidemiologic picture of Kawasaki disease in Beijing from 1995 through 1999. Pediatric infectious disease journal, 2002, 22(2):103-7.
17. Pierre R, Sue-Ho R, Watson D. Kawasaki syndrome in Jamaica. Pediatric infectious disease journal, 2000, 19(6):539-43.
18. Thisyakorn C, Thisyakorn U. Kawasaki disease in Thai children. Pediatric infectious disease journal, 1995, 14(4):324-5.
19. Yanagawa H et al. Epidemiologic pictures of Kawasaki disease in Japan from the nationwide incidence survey in 1991 and 1992. Pediatrics, 1995, 95:475-9.
20. Taubert KA, Rowley AH, Shulman ST. Nationwide survey of Kawasaki disease and acute rheumatic fever. Journal of pediatrics, 1991, 119:279-82.
21. Sadeghi E, Amin R, Agamee GH. Kawasaki syndrome: the Iranian experience. Eastern Mediterranean health journal, 2000, 7(1/2):16-25.
22. Sarram A. Kawasaki disease. New concepts and 15 case reports. Paper presented at the Annual Congress of the Iranian Society of Pediatrics and the 23rd Memorial Congress of Professor Mohammad Gharib, 4-8 May 2002, Thran, Iran [in Persian].
23. Kordivarian R. Kawasaki disease. Report of 13 cases from Alzahra Hospital, Isfahan. Isfahan medical sciences journal, 1337 (1998), 16(3):77-6 [in Persian].
24. Soleimani GhR, Siadati A. Etiologic evaluation of Kawasaki disease in patients referred to a pediatric medical center (Markaz Tebbi). Paper presented at the 14th International Congress of Pediatrics, 12-17 October, 2002, Tehran, Iran.
25. Research committee on Kawasaki disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesion in Kawasaki disorder. Tokyo, Ministry of Health and Welfare, 1984.
26. Belay ED et al. The incidence of Kawasaki syndrome in West Coast health maintenance organizations. Pediatric infectious disease journal, 2000, 19(9):826-32.
27. Burns JC et al. Intravenous gammaglobulin treatment and retreat-ment in Kawasaki disease. Pediatric infectious disease journal, 1998, 17(12): 1144-8.
28. Stockheim JA, Innocentini N, Shulman ST. Kawasaki disease in older children and adolescents. Journal of pediatrics, 2000, 137(2):250-2.
29. McCrindie BW et al. Summary and abstract of the sixth international Kawasaki disease symposium. Pediatric research, 2000, 47:544-70.
30. Koren G et al. Kawasaki diseases: review of risk factors for coronary aneurisms. Journal of pediatrics, 1986, 108:388-92.
31. Fukunishi M et al. Prediction of non-responsiveness to intravenous high-dose gammaglobolin therapy in patients with Kawasaki disease at onset. Journal of pediatrics, 2000, 137:172-6.
32. Hashino K et al. Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy. Pediatrics internationalto: official journal of the Japan Pediatric Society, 2001, 43(3):211-7.
33. Onouchi Z, Kawasaki T. Overview of pharmacological treatment of Kawasaki disease. Drugs, 1999. 58(5):813-22.
34. Raman V et al. Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy. Pediatric infectious disease journal, 2001, 20(6):635-7.
35. Dale RC et al. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. Journal of pediatrics, 2000, 137:723-6.
36. Wallace CA et al. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics, 2000, 105(6):E78.